Medicamen Organics Ltd
Pharmaceuticals & Biotechnology | Small Cap
Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio9.20
- Financial Ratio4.00
- Profitability Ratio9.60
- Efficiency Ratio3.67
- Coverage Ratio6.80
- Solvency Ratio9.50
- Liquidity Ratio3.36
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayNeutral
- 1 WeekBearish
- 1 MonthNeutral
Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.
Overall Valuation Score
P/E RATIO (TTM)
-9.16
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
-6.94
P/B RATIO
0.97
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
1.26
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-7.73
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹22.9 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth ratios indicate strong growth. High revenue growth, operating profit growth, EPS growth, and net income growth rates suggest the company is expanding its business and increasing its profitability. The asset growth rate, however, is concerning. Overall, the company is experiencing robust growth in key areas, indicating positive momentum and future potential.
| Growth Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue Growth Rate | 51.13 | -40.74 | |
| Operating Profit Growth Rate | 39.45 | -156.73 | |
| Earnings Per Share (EPS) Growth | 13.44 | -195.38 | |
| Asset Growth Rate | 54.03 | -12.8 | |
| Net Income Growth Rate | 54.58 | -199.26 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios present a mixed outlook. While capital expenditures are well-managed, the adjusted EPS, cash EPS, book value per share, and dividend per share suggest areas needing improvement. The company's earnings per share and book value are relatively low, and it does not currently pay dividends. Capital expenditures are being managed effectively. There are some areas requiring concern.
| Financial Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 1.88 | 3.46 | -3.3 |
| Cash Earnings Per Share (Cash EPS) | 3.88 | 4.09 | -2.56 |
| Book Value Per Share | 17.74 | 25.75 | 23.55 |
| Dividend Per Share (DPS) | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 0.3 | 2.5 | 1.7 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios look strong. High gross profit margin, ROCE, ROE, ROA, operating margin, and net margin suggest the company is generating profits efficiently and effectively. The company is performing well in terms of profitability, indicating sound financial health and potential for future growth. Overall, the company is doing good in profitability.
| Profitability Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Gross Profit Margin | 15.91 | 15.37 | -20.55 |
| Return on Capital Employed (ROCE) | 33.01 | 16.88 | -10.66 |
| Return on Equity (ROE) | 17.17 | 13.44 | -13.99 |
| Return on Assets (ROA) | 12.33 | 11.16 | -7.26 |
| Operating Margin | 18.76 | 17.31 | -16.57 |
| Net Margin | 10.37 | 10.6 | -17.76 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency ratios presents a mixed picture. While the days sales in inventory is efficient, the fixed asset turnover, inventory turnover, receivables turnover, receivable days, and capital turnover ratios suggest areas where the company could improve its operational efficiency. The company may be facing challenges in converting assets into sales and managing its working capital effectively. Enhancing efficiency can lead to improved profitability and better resource utilization.
| Efficiency Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.44 | 3.77 | 1.69 |
| Inventory Turnover Ratio | 3.46 | 4.74 | 3.03 |
| Receivables Turnover Ratio | 1.51 | 1.8 | 1.02 |
| Days Sales in Inventory Ratio | 105.49 | 77 | 120.46 |
| Receivable Days | 241.21 | 202.78 | 357.84 |
| Capital Turnover Ratio | 1.64 | 1.26 | 0.76 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios suggest a good ability to meet its interest obligations but some difficulties in covering equity dividends. The solid interest coverage ratio indicates the company can comfortably pay its interest expenses. The equity dividend coverage ratio raises concerns about the company's ability to cover dividend payments with its equity. Overall, the company is in a reasonable position to manage its debt obligations.
| Coverage Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Interest Coverage Ratio | 7.83 | 11.06 | -6.44 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency position looks strong. The company exhibits a very low debt ratio and debt-to-equity ratio, indicating minimal reliance on debt financing. A high equity ratio further supports this, reflecting a strong equity base. The negligible debt-to-asset ratio suggests that the company's assets are primarily financed by equity, reducing financial risk. Overall, the company is in a financially stable position with low leverage.
| Solvency Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debt Ratio | 0.01 | 0 | 0.04 |
| Debt to Equity Ratio | 0.01 | 0 | 0.04 |
| Equity Ratio | 0.99 | 1 | 0.96 |
| Debt To Asset Ratio | 0 | 0 | 0.02 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reveals that the company may face challenges in meeting its short-term obligations. While the quick ratio indicates some ability to cover immediate liabilities, the current and cash ratios raise concerns about overall liquidity. The negative operating cash flow ratio further exacerbates these concerns, suggesting potential difficulties in generating cash from core operations. The company needs to improve its short-term financial health.
| Liquidity Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Current Ratio | 1.21 | 1.62 | 1.75 |
| Quick Ratio | 0.95 | 1.36 | 1.27 |
| Cash Ratio | 0.02 | 0.14 | 0.06 |
| Operating Cash Flow Ratio | -0.16 | -0.16 | -0.21 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medicamen Organics Ltd | 6.30 | -6.94 | Neutral | -3.75 | -2.50 | -4.02 |
| 2 | Mono Pharmacare Ltd | 6.16 | 6.26 | Neutral | 8.00 | 1.75 | 3.00 |
| 3 | JFL Life Sciences Ltd | 6.07 | 9.43 | Neutral | 12.00 | 1.94 | 6.00 |
| 4 | Walpar Nutritions Ltd | 5.29 | 9.26 | Neutral | 6.66 | 2.09 | 3.00 |
| 5 | Mangalam Drugs and Organics Ltd | 4.50 | -1.07 | Neutral | -15.00 | -27.68 | -44.00 |
| 6 | Lasa Supergenerics Ltd | 4.39 | -2.61 | Highly Undervalued | -7.00 | -6.80 | -34.00 |
| 7 | Sunrest Lifescience Ltd | 4.17 | 7.06 | Highly Undervalued | 10.21 | 3.60 | 8.00 |
The management of Medicamen Organics Ltd. exhibits a mixed performance. The company shows significant revenue growth, with a 51% increase in sales, and a 55% compounded profit growth. However, the declining Operating Profit Margin (OPM) and high cash conversion cycle raise concerns about operational efficiency. Overall, the management demonstrates strengths in driving revenue and profit growth but needs to address operational efficiency and working capital management.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 51% | Strong revenue expansion |
| Profit Growth | 55% | Strong profit growth | |
| CONS | OPM % | 17.23% | Declining OPM |
| Cash Conversion Cycle | 175.39 Days | High Cash Conversion Cycle |
Financial Performance & Growth
Medicamen Organics demonstrates strong revenue expansion. Sales grew by 51% in Mar 2025. However, the Operating Profit Margin (OPM) declined from 18.76% in Mar 2024 to 17.23% in Mar 2025.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Sales Growth (%) | - | 51% |
| OPM (%) | 18.76% | 17.23% |
Capital Efficiency & Returns
The company exhibits moderate capital efficiency. While specific ROCE and ROE data for Mar 2025 is not available, the ROCE is at 16.60 and ROE is at 19.90. The cash conversion cycle is quite high. The Cash Conversion Cycle has 175.39 Days in Mar 2025.
| Metric | Mar 2025 |
|---|---|
| ROCE (%) | 16.60 |
| ROE (%) | 19.90 |
| Cash Conversion Cycle (Days) | 175.39 |
Financial Health & Prudence
Medicamen Organics has borrowings, with short-term borrowings at 12.20 in Mar 2025. The company does not have dividend payouts. The dividend payout is at 0.00% for both Mar 2024 and Mar 2025.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Short Term Borrowings | NA | 12.20 |
| Dividend Payout (%) | 0.00% | 0.00% |
Shareholding & Ownership Structure
Promoter holding is at 59.73% in Mar 2025, indicating a strong alignment of management and shareholder interests. FII holding is at 0.07% and DII holding is at 3.79%, suggesting some institutional interest.
| Metric | Sep 2024 | Mar 2025 |
|---|---|---|
| Promoter Holding (%) | 59.69% | 59.73% |
| FII Holding (%) | 0.14% | 0.07% |
| DII Holding (%) | 3.76% | 3.79% |
The risk assessment for Medicamen Organics is rated Orange, indicating moderate risk. The primary concerns arise from the company's extended cash conversion cycle, which ties up working capital. The high number of debtor days is a concern. However, the company’s sales and profit growth indicate positive momentum. This mixed risk profile suggests that while the company has growth potential, it also faces challenges that require careful management.
Accounting quality red flags
There are no red flags
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1022.56Bullish
- SMA 2022.24Bullish
- SMA 5020.99Bullish
- EMA 1022.55Bullish
- EMA 2022.18Bullish
- EMA 5021.65Bullish
- DEMA 1022.88Bullish
- DEMA 2022.85Bullish
- DEMA 5021.74Bullish
- TEMA 1022.85Bullish
- TEMA 2023.02Bearish
- TEMA 5022.69Bullish
- MACD0.49Bullish
- ADX31.63Strong Trend
- IndicatorValueSignal
- RSI62.71Neutral
- CCI82.86Neutral
- ROC 91.55Bullish
- ROC 146.51Bullish
- ROC 257.26Bullish
- Stoch K82.17Overbought
- Stoch D73.47Neutral
- IndicatorValueSignal
- BB Upper23.47Neutral
- BB Middle22.24Neutral
- BB Lower21.01Neutral
- ATR0.29Low Volatility
- IndicatorValueSignal
- MFI87.84Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1022.35Bullish
- SMA 2021.54Bullish
- SMA 5021.14Bullish
- EMA 1022.30Bullish
- EMA 2021.79Bullish
- EMA 5021.87Bullish
- DEMA 1022.91Bearish
- DEMA 2022.40Bullish
- DEMA 5020.83Bullish
- TEMA 1023.00Bearish
- TEMA 2023.06Bearish
- TEMA 5021.39Bullish
- MACD0.51Bullish
- ADX22.00Weak Trend
- IndicatorValueSignal
- RSI63.68Neutral
- CCI110.54Overbought
- ROC 96.51Bullish
- ROC 1411.71Bullish
- ROC 259.83Bullish
- Stoch K88.89Overbought
- Stoch D79.73Neutral
- IndicatorValueSignal
- BB Upper23.46Neutral
- BB Middle21.54Neutral
- BB Lower19.61Neutral
- ATR0.41Low Volatility
- IndicatorValueSignal
- MFI63.93Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1021.56Bullish
- SMA 2020.95Bullish
- SMA 5023.19Bearish
- EMA 1021.87Bullish
- EMA 2021.69Bullish
- EMA 5022.81Bullish
- DEMA 1022.53Bullish
- DEMA 2021.28Bullish
- DEMA 5020.89Bullish
- TEMA 1023.15Bearish
- TEMA 2022.16Bullish
- TEMA 50N/AN/A
- MACD-0.14Bullish
- ADX20.47Weak Trend
- IndicatorValueSignal
- RSI58.54Neutral
- CCI140.81Overbought
- ROC 912.53Bullish
- ROC 1414.50Bullish
- ROC 256.02Bullish
- Stoch K95.12Overbought
- Stoch D97.56Overbought
- IndicatorValueSignal
- BB Upper23.14Neutral
- BB Middle20.95Neutral
- BB Lower18.76Neutral
- ATR0.65Low Volatility
- IndicatorValueSignal
- MFI81.94Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1020.89Bullish
- SMA 2022.20Bullish
- SMA 5025.16Bearish
- SMA 10024.61Bearish
- SMA 20029.07Bearish
- EMA 1021.64Bullish
- EMA 2022.43Bullish
- EMA 5023.99Bearish
- EMA 10025.38Bearish
- EMA 20029.80Bearish
- DEMA 1021.33Bullish
- DEMA 2020.77Bullish
- DEMA 5022.51Bullish
- DEMA 10022.33Bullish
- DEMA 20020.08Bullish
- TEMA 1022.15Bullish
- TEMA 2020.41Bullish
- TEMA 5021.85Bullish
- TEMA 10023.17Bearish
- TEMA 200N/AN/A
- MACD-1.16Bullish
- ADX17.46Weak Trend
- IndicatorValueSignal
- RSI49.65Neutral
- CCI13.17Neutral
- ROC 14-4.58Bearish
- ROC 25-13.75Bearish
- Stoch K63.95Neutral
- Stoch D44.23Neutral
- IndicatorValueSignal
- BB Upper26.04Neutral
- BB Middle22.20Neutral
- BB Lower18.35Neutral
- ATR1.21High Volatility
- IndicatorValueSignal
- MFI22.49Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2025.00Bearish
- SMA 5029.67Bearish
- EMA 2025.18Bearish
- EMA 5030.63Bearish
- DEMA 2023.04Bearish
- DEMA 5020.18Bearish
- TEMA 2023.52Bearish
- TEMA 50N/AN/A
- MACD-1.62Bearish
- ADX16.65Weak Trend
- IndicatorValueSignal
- RSI36.05Neutral
- CCI-121.30Oversold
- ROC 14-11.01Bearish
- ROC 25-23.02Bearish
- Stoch K15.79Oversold
- Stoch D27.66Neutral
- IndicatorValueSignal
- BB Upper31.13Neutral
- BB Middle25.00Neutral
- BB Lower18.86Neutral
- ATR3.08Low Volatility
- IndicatorValueSignal
- MFI59.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
No results for this timeframe
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 624.79Bearish
- SMA 1230.55Bearish
- SMA 2443.26Bearish
- EMA 626.12Bearish
- EMA 1231.32Bearish
- EMA 2443.26Bearish
- DEMA 623.46Bullish
- DEMA 1220.67Bullish
- DEMA 24N/AN/A
- TEMA 624.74Bearish
- TEMA 12N/AN/A
- TEMA 24N/AN/A
- MACDN/AN/A
- ADXN/AN/A
- IndicatorValueSignal
- RSIN/AN/A
- CCIN/AN/A
- ROC 25N/AN/A
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper54.94Neutral
- BB Middle34.32Neutral
- BB Lower13.70Neutral
- ATR12.25Low Volatility
- IndicatorValueSignal
- MFI45.29Neutral